| 1 | GSDH, PRKAG2, WPW
|
| Severe hypertrophic cardiomyopathy in an infant with a novel PRKAG2 gene mutation: potential differences between infantile and adult onset presentation.
|
| Kelly BP, Russell MW, Hennessy JR, Ensing GJ.
|
| Pediatr Cardiol 30(8):1176-9.
2009
|
| 2 | PRKAG2, WPW
|
| Nodoventricular accessory pathways in PRKAG2-dependent familial preexcitation syndrome reveal a disorder in cardiac development.
|
| Tan HL, van der Wal AC, Campian ME, Kruyswijk HH, ten Hove Jansen B, van Doorn DJ, Oskam HJ, Becker AE, Wilde AA.
|
| Circ Arrhythm Electrophysiol 1(4):276-81. Epub 2008 Sep 12.
2008
|
| 3 | PRKAG2, WPW
|
| Ventricular pre-excitation and cardiac hypertrophy mimicking hypertrophic cardiomyopathy in a Turkish family with a novel PRKAG2 mutation.
|
| Bayrak F, Komurcu-Bayrak E, Mutlu B, Kahveci G, Basaran Y, Erginel-Unaltuna N.
|
| Eur J Heart Fail 8(7):712-5. Epub 2006 May 22.
2006
|
| 4 | PRKAG2, WPW
|
| Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy.
|
| Gollob MH, Seger JJ, Gollob TN, Tapscott T, Gonzales O, Bachinski L, Roberts R.
|
| Circulation 104(25):3030-3. 2001
|
| 5 | WPW
|
| Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndromemaps to a locus on chromosome 7q3.
|
| MacRae CA, et al.
|
| J Clin Invest 96 : 1216-1220. 1995
|